Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Inclusion Criteria: * Must have given written informed consent * Must be ≥ 18 years of age and not of child bearing potential * Must have an ulcer in which the presence of MRSA has been identified, but which is not clinically infected * Must have an ulcer size not to extend beyond the inner borders of the dressing Exclusion Criteria: * Is a female of child bearing years or who could become pregnant * Is \< 18 years of age * Has an clinically infected skin ulcer * Has a ulcer that is being treated with a topical antimicrobial agent or has been treated with a topical antimicrobial agent during 3 days prior to enrolment * Has been using systemic antibiotics during 7 days prior to enrolment into this study * Has an ulcer which is identified as malignant in origin (e.g. Marjolin's ulcer) * Has an ulcer size beyond the inner borders of the dressing * Is septic or has other signs of an invasive infection * Has used any investigational drug within 30 days preceding study participation. * Suffers from a condition, which, in the opinion of the Investigator, would compromise his or her safety. * Suffers from a condition which, in the opinion of the Investigator, would compromise the quality of the data. * Has a known allergy to any of the products that are part of this protocol * Suffers from a condition which, in the opinion of the Investigator, would seriously interfere negatively with the normal parameters of immune response to an infection. * Is using any of the prohibited concomitant medications or treatments